Back to search

Article

Brequinar and Dipyridamole in Combination Exhibits Synergistic Antiviral Activity Against SARS-CoV-2 <i>in vitro</i> : Rationale for a host-acting antiviral treatment strategy for COVID-19

2022-03-31

Abstract excerpt

<h4>ABSTRACT</h4> The continued evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has compromised the efficacy of currently available vaccines and monoclonal antibody (mAb)-based treatment options for COVID-19. The limited number of authorized small-molecule direct-acting antivirals present challenges with pill burden, the necessity for intravenous administration or potential drug interact...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
fb723c34-e4eb-580e-9e9f-e959186b07cd
DOI
10.1101/2022.03.30.486499
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Brequinar and Dipyridamole in Combination Exhibits Synergistic Antiviral Activity Against SARS-CoV-2 <i>in vitro</i> : Rationale for a host-acting antiviral treatment strategy for COVID-19DOI 10.1101/2022.03.30.486499
Select a neighboring publication to make it the new centre.